REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
June 14, 2022
FROM
TRACY REECE, Chief Probation Officer, Probation Department
SUBJECT
Title
Application and Acceptance of Intranasal Naloxone Hydrochloride from California Department of Health Care Services’ Naloxone Distribution Project
End
RECOMMENDATION(S)
Recommendation
1. Approve application for 600 units of intranasal Naloxone Hydrochloride from California Department of Health Care Services.
2. Accept 600 units of intranasal Naloxone Hydrochloride from California Department of Health Care Services.
(Presenter: Tracy Reece, Chief Probation Officer, 387-5692)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Operate in a Fiscally-Responsible and Business-Like Manner.
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of additional Discretionary General Funding (Net County Cost). The Probation Department (Department) will receive the Naloxone Hydrochloride at no cost. The Department will report any successful overdose reversals to California Department of Health Care Services.
BACKGROUND INFORMATION
Naloxone Hydrochloride (Naloxone) is a life-saving medication that reverses an opioid overdose, while having little to no effect in the event it is administered on an individual who does not have opioids in their system. Naloxone works by blocking the opioid receptor sites, reversing the toxic effects of the overdose. Naloxone requires a prescription but is not a controlled substance. It has few known adverse effects, and no potential for abuse.
Naloxone is administered when a patient is showing signs of opioid overdose. The medication can be given by intranasal spray, intramuscular (into the muscle), subcutaneous (under the skin), or by intravenous injection. The Department is applying for 600 units of Naloxone intranasal spray.
The Naloxone Distribution Project (NDP) is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the California Department of Health Care Services (DHCS) to combat opioid overdose-related deaths throughout California. The NDP aims to reduce opioid overdose deaths through the provision of free Naloxone, in its nasal spray formulation. Through the NDP, qualified organizations and entities are able to request free Naloxone from DHCS and have it directly shipped to their address. Since October 2018, the NDP has distributed over 1,000,000 units of Naloxone, and recorded over 57,000 overdose reversals.
DHCS considers the Department to be a qualified organization, as a law enforcement and criminal justice partner. The Department is requesting 600 units of Naloxone to be carried by Probation Officer IIs, Probation Officer IIIs, and Supervising Probation Officers while serving approximately 20,000 adult offenders and 3,500 youthful offenders throughout the County. Naloxone intranasal spray has an estimated shelf life of up to 36 months. The Department previously received Naloxone under this program in 2019 and 2020. The Department’s Naloxone use has resulted in three overdose reversals.
PROCUREMENT
N/A
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Jamie Ryan, Deputy County Counsel, 387-5455) on April 26, 2022; Finance (Kathleen Gonzalez, Administrative Analyst III, 387-5412) on May 5, 2022; and County Finance and Administration (Robert Saldana, Deputy Executive Officer, 387-5423) on May 24, 2022.